Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 2/3 1

Status

Unknown 3Completed 3

Sponsor Class

NIH 4OTHER 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Carcinoma, Hepatocellular 13Colorectal Neoplasms 7Liver Neoplasms 6Colonic Neoplasms 4Rectal Neoplasms 3Esophageal Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Appendiceal Neoplasms 2Vomiting 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma 1Salivary Gland Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Nausea 1Multiple Myeloma 1Meningioma 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Liver Neoplasms × Thalidomide × Gastrointestinal × Clear all
NCT07321613 2026-01-07

Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

Shanghai Zhongshan Hospital

Completed
545 enrolled
Gastrointestinal

Liver Neoplasms

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00058487 2013-07-18

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00006006 2013-02-11

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

National Cancer Institute (NCI)

Phase 2 Completed
38 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00728078 2009-02-09

LDT-RFA

Sun Yat-sen University

Phase 2/3 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00006198 2005-06-24

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

National Center for Research Resources (NCRR)

Phase 2 Unknown
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡